Evidence map›Paper›PMID 35889048›Full record

ReviewMicroorganisms2022

Phage Products for Fighting Antimicrobial Resistance.

Yuanling Huang, Wenhui Wang, Zhihao Zhang, Yufeng Gu, Anxiong Huang, Junhao Wang, Haihong Hao

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Bacteriophages AgainstViruses · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Case reports in orthopedics · 2026
    Article
  12. Review
  13. Article
  14. Effect of egg cultivation methods onFood science and biotechnology · 2025
    Article
  15. Review
  16. Methods of Controlling Microbial Contamination of Food.Pathogens (Basel, Switzerland) · 2025
    Review
  17. Biological Characteristics and Genomic Analysis ofCurrent issues in molecular biology · 2025
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuanling HuangNational Reference Laboratory of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.
Wenhui WangNational Reference Laboratory of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.
Zhihao ZhangNational Reference Laboratory of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.
Yufeng GuNational Reference Laboratory of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.
Anxiong HuangNational Reference Laboratory of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.ORCID 0000-0001-5790-7015
Junhao WangNational Reference Laboratory of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.
Haihong HaoNational Reference Laboratory of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430070, China.ORCID 0000-0003-0199-5700
Huazhong Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) has become a global public health issue and antibiotic agents have lagged behind the rise in bacterial resistance. We are searching for a new method to combat AMR and phages are viruses that can effectively fight bacterial infections, which have renewed interest as antibiotic alternatives with their specificity. Large phage products have been produced in recent years to fight AMR. Using the "one health" approach, this review summarizes the phage products used in plant, food, animal, and human health. In addition, the advantages and disadvantages and future perspectives for the development of phage therapy as an antibiotic alternative to combat AMR are also discussed in this review.

Indexed as

advantages and disadvantages of phage therapyantimicrobial resistancedevelopment prospectsphage products

Identifiers

PMID35889048
PMCPMC9324367
OpenAlexW4283757261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.